Impact Factor 2021: 3.041 (@Clarivate Analytics)
5-Year Impact Factor: 2.776 (@Clarivate Analytics)
Impact Factor Rank: 10/24, Q2 (Tropical Medicine)
  • Users Online: 1661
  • Print this page
  • Email this page
This article has been cited by
1Exploring Innovative Leishmaniasis Treatment: Drug Targets from Pre-Clinical to Clinical Findings
Wanessa Santana,Simone S. C. Oliveira,Mariana H. Ramos,André L. S. Santos,Silvio S. Dolabella,Eliana B. Souto,Patrícia Severino,Sona Jain
Chemistry & Biodiversity.2021;18(9)
2Treatment of Cutaneous Leishmaniasis and Insights into Species-Specific Responses: A Narrative Review
Rajamanthrilage Kasun Madusanka,Hermali Silva,Nadira D. Karunaweera
Infectious Diseases and Therapy.2022;11(2)695
3Efficacy of amiodarone and voriconazole combination therapy in cutaneous leishmaniasis in the mice experimentally infected with Leishmania major
S. Bahrami,A. Oryan,E. Bemani
Journal of Infection and Chemotherapy.2021;27(7)984
4Fabrication and Evaluation of Voriconazole Loaded Transethosomal Gel for Enhanced Antifungal and Antileishmanial Activity
Mudassir Farooq,Faisal Usman,Sumera Zaib,Hamid Saeed Shah,Qazi Adnan Jamil,Fatima Akbar Sheikh,Ajmal Khan,Sameh Rabea,Soheir A. A. Hagras,Gaber El-Saber Batiha,Imtiaz Khan